Focus on Diabetes Care

Back to articles

Once-weekly dulaglutide beats out insulin glargine in type 2 diabetes


Individuals with type 2 diabetes who were taking prandial lispro (Humalog—Eli Lilly) in combination with once-weekly dulaglutide (Trulicity—Eli Lilly) achieved better glycemic control than those on prandial lispro plus bedtime glargine (Lantus—Sanofi–Aventis), according to results of a recent trial.